From our results, we demonstrated the negative correlation between TMPRSS4 expression and TNBC sensitivity to irradiation suggested that TMPRSS4 could be considered as a potential therapeutic target for enhancing breast cancer radiotherapy efficacy especially the triple negative breast cancer. This evidence concerns the gene TMPRSS4 and triple-negative breast carcinoma.